Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Supraflex Cruz 60 Micron Stent Strut Versus the Ultimaster Tansei 80 Micron Stent Strut in High Bleeding Risk PCI Population

NCT04500912 is registered in ClinicalTrials.gov with Pieter C.Smits as lead sponsor.

NCT NCT04500912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Supraflex Cruz 60 Micron Stent Strut Versus the Ultimaster Tansei 80 Micron Stent Strut in High Bleeding Risk PCI Population
Lead sponsor
Pieter C.Smits
Phase
Not applicable
Overall status
Completed
Start date
September 14, 2020
Completion date
September 1, 2023
Enrollment
736 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease, high bleeding risk, pci